Saturday 17 October 2026 Export URGN’s income statement to Excel — free account

Urogen Pharma

Urogen Pharma’s revenue for fiscal 2025 (year ended December 2025) was $109.8 million, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 199.2%, EPS grew 73.3%, free cash flow grew 17.3% and total debt rose 56.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

34.56 2.05 −5.60%

Follow URGN

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −30.0×
Dividend yield: —
F-score: 2/9
Altman Z: −5.16
Beneish M: −1.42
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	2	3	3
ROE Full definition →		366.31%	268.63%	156.08%	86.49%
ROA Full definition →		(67.62%)	(63.14%)	(53.15%)	(42.33%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(129.64%)	(109.45%)	(71.07%)	(56.08%)
Average Days of Receivables Full definition →		74.51	109.98	143.96	171.65
Free Cash Flow per Share Full definition →		(2.87)	(3.38)	(3.31)	(3.16)
Free Cash Flow Full definition →		(138.12)	(162.73)	(166.03)	(159.13)
Capital Expenditures Full definition →		(0.39)	(0.29)	(0.30)	(0.22)
Other line items
Cash ROIC Full definition →		(102.25%)	(114.59%)	(80.26%)	(94.40%)
Accounts Receivable Turnover Full definition →		4.54	4.11	3.74	3.48
Accounts Payable Turnover Full definition →		0.51	0.45	0.43	0.49
Inventory Turnover Full definition →		1.46	0.97	1.00	1.09
Average Days of Payables Full definition →		821.49	812.78	904.97	843.84
Days of Inventory on Hand Full definition →		261.80	482.80	535.65	519.45
Tax Rate Full definition →		0.02	0.00	(0.04)	0.00
Research and Development Expense of Revenue Full definition →		70.13%	61.12%	44.72%	32.46%
Selling, General and Administrative Expense of Revenue Full definition →		156.04%	141.27%	122.15%	93.71%
Share Based Compensation of Revenue Full definition →		12.57%	10.89%	9.62%	8.54%
Interest Coverage Full definition →		(8.63)	(8.14)	(7.00)	(4.11)
Operating CF/Net income Full definition →		0.84	1.06	1.24	1.63
Depreciation/Fixed assets Full definition →		(4.08)	(2.46)	(1.24)	(2.62)
Capex/Depreciation Full definition →		0.14	0.18	0.39	0.14
Revenue per Share Full definition →		2.01	2.28	2.80	3.75
Operating CF per Share Full definition →		(2.87)	(3.38)	(3.30)	(3.15)
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly